Pegcetacoplan acetate is a pegylated complement C3 inhibitory peptide that functions by binding to complement component 3 (C3) and its activation fragment C3b. This compound is utilized in the study of complement-mediated diseases, including age-related macular degeneration, C3 glomerulopathy, geographic atrophy (GA), and autoimmune hemolytic anemia.
Molecular Weight:
1501.7
Purity:
97.10%
Formula:
(C2H4O)nC170H248N50O47S4.xC2H4O2
Target:
Complement System
* VAT and and shipping costs not included. Errors and price changes excepted
